In the last two decades, the primary and secondary prevention measures of CAD have improved significantly; therefore, it is important to know if individuals with FV Leiden and/or prothrombin G20210A—as the most common thrombophilic traits in the general population—currently require special management. The gene discussed is F2; the disease is coronary artery disorder.